Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs rivaroxaban for prevention of deep venous thrombosis after total knee arthroplasty
TCTR20201226005Phase 4Completed
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, rivaroxaban in venous thromboembolism (VTE), sponsored by Faculty of Medicine, Prince of Songkhla University. Started Aug 2016; status: completed.
02
Drugs
aspirinrivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on TCTR20201226005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201226005.